[Evidence report for the S3 guideline on diagnosis and treatment of gout: treatment of comorbidities]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005405
German
Original Title:
Behandlung von Komorbiditäten: Evidenzbericht zur S3-Leitlinie Diagnostik und Therapie der Gicht
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/v22-06.html
Year Published:
2023
URL for published report:
https://www.iqwig.de/download/v22-06e_behandlung-von-komorbiditaeten_evidenzbericht_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Gout
- Gout Suppressants
- Sodium Chloride Symporter Inhibitors
- Sodium Potassium Chloride Symporter Inhibitors
- Sodium-Glucose Transporter 2 Inhibitors
- Comorbidity
- Disease Management
Keywords
- Sodium Chloride Symporter Inhibitors
- Sodium Potassium Chloride Symporter Inhibitors
- Sodium-Glucose Transporter 2 Inhibitors
- Gout
- Systematic Review
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.